

Hansen et al., “Immunochemical Characterization of and Isolation of the Gene for a Borrelia burgdorferi Immunodominant 60-Kilodalton Antigen Common to a Wider Range of Bacteria,” Infect. Simpson et al., “Reactivity of Human Lyme Borreliosis Sera with a 39-Kilodalton Antigen Specific to Borrelia burgdorferi,” J. Barbour et al., “Variation in a Major Surface Protein of Lyme Disease Spirochete,” Infect. Kawabata et al., “Genetic and Immunological Analyses of VIs (VMP-like sequences) of Borrelia burgdorferi,” Microb. Schwan et al., “Distribution and Molecular Analysis of Lyme Disease Spirochetes, Borrelia burgdorferi, Isolated from Ticks throughout California,” J. Rosa et al., “Recombination between Genes Encoding Major Outer Surface Proteins A and B of Borrelia burgdorferi,” Mol. DeSilva et al., “Growth and Migration of Borrelia burgdorferi in Ixodes Ticks During Blood Feeding,” Am.

Siene et al., “Antibody-resistant Mutants of Borrelia burgdorferi: In Vitro Selection and Characterization,” J. Mather et al., “Ixodes Saliva: Vector Competence for Borrelia burgdorferi and Potential Vaccine Strategies”, in VII International Congress on Lyme Borreliosis, San Francisco, CA 1996.Ī.

DeSilva et al., “Borrelia burgdorferi OspA is an Arthropod-specific Transmission-blocking Lyme Disease Vaccine,” J. Spirochetal and Tick-borne Disease, 3:67-79 (Mar. Philipp et al., “Safety and Immunogenicity of Recombinant Outer Surface Protein A (OspA) Vaccine Formulations in the Rhesus Monkey,” J. Lazar et al, “Transforming Growth Factor Alpha: Mutation of Aspartic Acid 47 and Leucine 48 Result in Different Biological Activities”, Mol Cell Biol, vol. 1306-1310, 1990.*īurgess et al, “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding Growth Factor-1. 315, 1991.*īowie et al, “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”, Science, vol. Abbas et al, Cellular and Molceular Immunology, (textbook), p.
